{"id":"W4398255859","doi":"10.1017/cjn.2024.120","title":"P.012 A global, long-term, prospective, observational registry of patients with AQP4+ NMOSD treated with complement component 5 inhibitor therapies eculizumab or ravulizumab","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Eculizumab; Medicine; Observational study; Dosing; Population; Pediatrics; Adverse effect; Intensive care medicine; Internal medicine; Immunology; Immune system; Complement system","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009119722,0.0001978721,0.0002710138,0.0008859502,0.0009322655,0.0007726983,0.0005879488,0.0002748362,0.01085717],"category_scores_gemma":[0.002835947,0.0001808699,0.000374657,0.002488851,0.0003658496,0.0003383426,0.0005682043,0.0005303933,0.001414844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002406269,"about_ca_system_score_gemma":0.009916422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2737441,"about_ca_topic_score_gemma":0.2819473,"domain_scores_codex":[0.9990821,0.0001050648,0.00009180891,0.0001913218,0.0003134364,0.0002162496],"domain_scores_gemma":[0.9960032,0.0003896214,0.001251939,0.0002176462,0.001274834,0.0008628138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005469131,0.000100635,0.9560406,0.0001488864,0.0001376697,0.0001899588,0.00006989633,0.00009519699,0.0003750035,0.0002913497,0.02911222,0.01289172],"study_design_scores_gemma":[0.0002482763,0.000196058,0.9832314,0.0001106165,0.0001421371,0.0004988258,0.0002503156,0.0004913747,0.0002045797,0.0001398887,0.01447104,0.00001542064],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8199757,0.002587124,0.001460159,0.002977161,0.0002436656,0.0007630726,0.1376915,0.0001472246,0.03415442],"genre_scores_gemma":[0.9470878,0.001061485,0.00195721,0.001020298,0.000195392,0.0004213604,0.04401777,0.00005238311,0.004186305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2737441,"threshold_uncertainty_score":0.5443015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03922132816123652,"score_gpt":0.2749463947731343,"score_spread":0.2357250666118977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}